StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
002296.SZ$10.21+2.00%
Fair $10.21+0.0%

002296.SZ

HeNan Splendor Science & Technology Co., Ltd.

Industrials / RailroadsShenzhen

$10.21

+0.20 (+2.00%)

Fairly Valued+0.0%Fair Value $10.21Fund rank 36/100 · Data gapFallback financials|
SA 42/C
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $154.7M · quality 76.7/100

Data gap 36/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 75/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

42/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 002296.SZLocal privado en este navegador · HeNan Splendor Science & Technology Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$4.0B

P/E

22.7x

↑

EV/EBITDA

14.2x

↑

ROE

7.7%

↑

Gross Margin

60.0%

↑

Debt/Equity

0.00

↓
52-Week Range$10
$10$15

TradingView lightweight chart

002296.SZ price, volumen y niveles de valoración

Último $10.21Periodo +48.4%
Fair value: $10.21

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+10.5%

FCF CAGR

+24.5%

FCF margin

17.6%

FCF / Net income

0.83x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $878.5M · net income $187.1M · FCF $154.7M

2022-FY → 2025-FY

Gross margin

60.0%+12.1% pts

Operating margin

37.4%+20.6% pts

Net margin

21.3%+5.3% pts

FCF margin

17.6%+5.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$878.5M$878.5M$1.27B$740.2M$651.9M
Net Income$187.1M$187.1M$274.5M$164.4M$104.0M
EBITDA$259.0M$259.0M$343.1M$233.6M$165.9M
EPS0.480.480.710.440.28
Gross Margin60.0%60.0%44.3%43.6%47.8%
Operating Margin37.4%37.4%28.3%15.4%16.8%
Net Margin21.3%21.3%21.6%22.2%16.0%
Balance Sheet
Debt/Equity0.000.000.000.00—
Current Ratio2.582.58———
Cash Flow
Free Cash Flow$154.7M$154.7M$144.6M$165.1M$80.2M
Returns
ROE7.7%7.7%11.9%8.3%5.8%
Valuation
P/E22.6922.6912.5118.9429.54
EV/EBITDA14.1614.169.2112.1216.92
P/B1.641.641.481.571.71
Growth & Yield
Revenue Growth-30.9%-30.9%71.8%13.5%—
EPS Growth-32.4%-32.4%62.8%54.5%—
Dividend Yield1.9%1.9%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

23.6%

exigente

EPS terminal req.

$0.91

Spread vs growth

-56.0%

5Y implied EPS CAGR

18.0%

exigente

EPS terminal req.

$1.10

Spread vs growth

-50.4%

10Y implied EPS CAGR

13.9%

razonable

EPS terminal req.

$1.77

Spread vs growth

-46.3%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -6.1%

Total return

-6.1%

Start / end P/E

15.6x → 21.3x

EPS bridge

0.71 → 0.48

Residual

-11.7%

EPS growth-32.4%
Multiple rerating+36.1%
Dividend+1.9%
Residual / FX / buybacks / cross-term-11.7%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.